The role of DMD as a tumor suppressor in sarcomas is strengthened by the observation that dystrophin-deficient mdx mice, which are murine models for Duchenne muscular dystrophy, spontaneously develop rhabdomyosarcomas in 6–9% of cases [4]. This evidence concerns the gene DMD and rhabdomyosarcoma.